Guillermo Lievano, DO
Obstetrics & Gynecology · Miami, FLNPI 1992785026
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Intuitive Surgical at 44.2% of the total. Reporting peaked in 2022 at $3,195 and has fallen 81.7% since, to $583 in 2025. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $73.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Sumitomo Pharma America, Inc.$2K
- AbbVie$402
- Hologic Sales And Service, LLC$358
- Astellas Pharma US Inc$257
- Mayne Pharma Commercial LLC$235
- plus $1K from 20 others
Across 152 payments — averaging $16,623 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Organon$2.2M
- Sumitomo Pharma America, Inc.$165K
- AbbVie$122K
- Myovant Sciences GmbH$46K
- Bayer$9K
- Myovant Sciences Inc.$4K
What the payments were for
- Travel & lodging$1,01515%
- Food & beverage$2,66239%
- Education$3,11846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 1 | $3,000 |
| Sumitomo Pharma America, Inc. | 10 | $1,519 |
| AbbVie(2 entities) | 20 | $402 |
| Hologic Sales And Service, LLC | 8 | $358 |
| Astellas Pharma US Inc | 9 | $257 |
| Mayne Pharma Commercial LLC | 8 | $235 |
| Gynesonics, Inc. | 2 | $153 |
| Medicem Inc. | 2 | $103 |
| Organon | 2 | $93 |
| Millicent US Inc | 4 | $79 |
| Bayer | 4 | $78 |
| Myovant Sciences Inc. | 3 | $76 |
| Evofem Biosciences, Inc. | 3 | $61 |
| Coopersurgical, Inc. | 3 | $60 |
| Biogen | 2 | $51 |
| Pfizer | 2 | $50 |
| Channel Medsystems, Inc. | 1 | $47 |
| Exeltis, USA Inc. | 1 | $25 |
| Mylan Pharmaceuticals Inc. | 1 | $22 |
| Osiris Therapeutics Inc. | 1 | $21 |
| Medtronic | 1 | $20 |
| BD | 1 | $20 |
| Novo Nordisk | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Meditrina | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,795 in reported general payments places this provider in the 90th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Miami
- Youssef MouhayarMiami$162K
- Rebeca MartinezMiami$108K
- Jason JamesMiami$97K
- Peter KhamvongsaMiami$67K
- Abdulrahman SinnoMiami$67K
- Ingrid ParedesMiami$65K
- Karen Salazar ValdesMiami$29K
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.